Table III.

Main outcomes of interest

Parameter	Results
In-hospital/by discharge (n = 75)
Any intracranial hemorrhage:	12 (16)
sICH	4 (5.3)
asICH	8 (10.7)
In-hospital death	7 (9.3)
NIHSS# on discharge:	4 (2–8)
Range	0–23
mRS at discharge:	1 (1–3)
Range	0–6
Stent patent# on discharge	66 (94.3)
DUS in-stent velocities:
PSV [cm/s]	69 (53–91)
EDV [cm/s]	20 (12–26)
Any in-stent material	0 (0)
90-day outcomes† (n = 66)
New stroke by 90 days, any:	2 (3)
Ipsilateral	1 (1.5)
Contralateral	0
Posterior circulation	1 (1.5)
90-day death (total*)	9 (12.0)
NIHSS at 90 days	3 (0–5)
mRS‡ at 90 days	1 (1–2)
Stent patent¥ by 90 days	59 (92.2)
Any in-stent material§	0 (0)
Stent occluded by 90 days	5 (7.8)
DUS in-stent velocities:
PSV [cm/s]	64 (55–84)
EDV [cm/s]	24 (21–30)

sICH – symptomatic intracranial hemorrhage, asICH – asymptomatic intracranial hemorrhage, NIHSS – National Institutes of Health Stroke Scale Score, mRS – modified Rankin scale, DUS – Duplex ultrasound, PSV – peak-systolic velocity, EDV – end-diastolic velocity.

^†In patients alive at 90 days, unless specified otherwise,

^§in patent stents,

^*8 deaths as stroke consequence; one cardiac death,

^#in alive patients and those showing stent occlusion on DUS prior to death (n = 70 eligible),

^‡including last available DUS in patients who died,

^¥in patients alive at 90 days, unless occlusion diagnosed prior to death between discharge and 90 days; (n = 64 eligible at 90 days).